Related Experiment Video
Updated: Mar 18, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma
1Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.
Abstract:
Ras-Association Domain Family 10 (RASSF10) is the last identified member of the RASSF family. The functional characteristics of this new gene in human cancers remain largely unclear. Here, we examined RASSF10 for the biological functions and related molecular mechanisms in hepatocellular carcinoma (HCC). We found that RASSF10 is expressed in normal human liver tissue, but is silenced or down-regulated in 62.5% (5/8) of HCC cell lines. The mean expression level of RASSF10 was significantly lower in primary HCCs compared with their adjacent normal tissues (P<0.005, n=52). The promoter methylation contributes to the inactivation of RASSF10 as demonstrated by bisulfite genomic sequencing and demethylation treatment analyses. Transgenic expression of RASSF10 in silenced HCC cell lines suppressed cell viability, colony formation and inhibited tumor growth in nude mice (QGY7703, P<0.01; HepG2, P<0.05). Furthermore, RASSF10 was shown to induce the cell accumulation in G1 phase with the increase of p27, as well as the decrease of cyclinD1 and CDK2/CDK4. Over-expression of RASSF10 also inhibited HCC cells migration (P<0.01) or invasion (P<0.05). Adhesion genes array revealed that Matrix Metalloproteinase 2 (MMP2) was a downstream effector of RASSF10. RASSF10 acting as a tumor suppressor to inhibit HCC invasion partially mediated by Focal Adhesion Kinase or p38 MAPK to decrease the accumulation of MMP2. Our study suggests that RASSF10 acts as a tumor suppressor for HCC.
Insights
Ras-Association Domain Family 10 (RASSF10) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Silencing of RASSF10 promotes HCC cell viability, growth, and metastasis, indicating its crucial role in liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ras-Association Domain Family 10 (RASSF10) is a recently identified member of the RASSF family.
- Its specific functions in human cancers, particularly hepatocellular carcinoma (HCC), are not well understood.
Purpose of the Study:
- To investigate the biological functions and molecular mechanisms of RASSF10 in hepatocellular carcinoma (HCC).
- To determine if RASSF10 acts as a tumor suppressor in HCC development and progression.
Main Methods:
- Analysis of RASSF10 expression in HCC cell lines and primary tumors.
- Assessment of promoter methylation as a mechanism for RASSF10 inactivation.
- In vitro and in vivo experiments using transgenic RASSF10 expression in HCC cell lines.
- Cell cycle analysis and investigation of downstream effectors, including MMP2, Focal Adhesion Kinase, and p38 MAPK.
Main Results:
- RASSF10 is frequently silenced or downregulated in HCC cell lines and tumors, often due to promoter methylation.
- Restored RASSF10 expression suppressed HCC cell viability, colony formation, and tumor growth in vivo.
- RASSF10 induced G1 cell cycle arrest and inhibited HCC cell migration and invasion.
- RASSF10's tumor-suppressive effects were partially mediated by regulating MMP2, Focal Adhesion Kinase, and p38 MAPK signaling.
Conclusions:
- RASSF10 functions as a tumor suppressor in hepatocellular carcinoma.
- RASSF10 inactivation through promoter methylation contributes to HCC progression.
- RASSF10 represents a potential therapeutic target for HCC.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
The Ras Gene
Ras is a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
MAPK Signaling Cascades
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...